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Macromolecular structure phasing 
by neutron anomalous diffraction
Maxime G. Cuypers1,2, Sax A. Mason2, Estelle Mossou1,2, Michael Haertlein2, 
V. Trevor Forsyth1,2 & Edward P. Mitchell1,3
In this report we show for the first time that neutron anomalous dispersion can be used in a 
practical manner to determine experimental phases of a protein crystal structure, providing a new 
tool for structural biologists. The approach is demonstrated through the use of a state-of-the-art 
monochromatic neutron diffractometer at the Institut Laue-Langevin (ILL) in combination with crystals 
of perdeuterated protein that minimise the level of hydrogen incoherent scattering and enhance the 
visibility of the anomalous signal. The protein used was rubredoxin in which cadmium replaced the iron 
at the iron-sulphur site. While this study was carried out using a steady-state neutron beam source, 
the results will be of major interest for capabilities at existing and emerging spallation neutron sources 
where time-of-flight instruments provide inherent energy discrimination. In particular this capability 
may be expected to offer unique opportunities to a rapidly developing structural biology community 
where there is increasing interest in the identification of protonation states, protein/water interactions 
and protein-ligand interactions – all of which are of central importance to a wide range of fundamental 
and applied areas in the biosciences.
The direct visualisation of protonation states and water networks surrounding biological macromolecules has 
been a longstanding challenge in structural biology1. Neutron protein crystallography is a developing technique 
that is able to yield this information in a way that relates directly to biological structure and function2–4. At the 
ILL, major developments continue for neutron protein crystallography – these are mostly focused on the LADI 
Laue instrument that covers larger protein systems5,6. Smaller systems can be studied at high resolution using 
the monochromatic D19 diffractometer7,8. Further investments are also being made at current and future neu-
tron sources and high priority is being placed on their exploitation for structural biology. Examples include the 
High-Flux Reactor (HIFR)9 and Spallation Neutron Source (SNS) at Oak Ridge National Laboratory10, and at the 
J-PARC neutron source in Japan11. The European Spallation Source (ESS) is currently being built in Sweden and 
will feature the NMX protein diffractometer as one of its first instruments.
The insights provided are crucial for an understanding of enzymatic catalysis, redox reactions, and protein 
engineering relevant to areas such as bio-fuel cells, biosensors and biochips, and drug design. Here we show 
that it is possible to use neutron anomalous scattering to phase protein crystal structures in a practical fashion. 
This study derives from early pioneering work in which Schoenborn and colleagues measured anomalous dif-
ferences in myoglobin-Cd crystals12, as originally suggested by Ramaseshan13,14. This was later extended to a 
two-wavelength approach by Bartunik15. Since then, neutron facilities have evolved, becoming more brilliant 
and using increasingly efficient detector systems; this, with the ready availability of perdeuteration technologies 
for the preparation of optimised protein samples16,17, opens the door to practicable phasing of protein crystal 
structures using neutron anomalous diffraction. Beyond reactor neutron sources, this capability is likely to be 
also of interest to researchers that are operating and developing instrumentation at spallation neutron sources, 
which provide high performance time-of-flight technologies and therefore offer precise energy discrimination. 
This permits an optimised approach for neutron anomalous scattering. However, the application of this technique 
has not yet been seriously developed as an approach that could become readily available to the structural biology 
community.
Results
In the current study, perdeuterated Pyrococcus furiosus rubredoxin18 was produced with the iron atom from the 
[Fe-4S] cluster replaced by the 113Cd isotope. Neutron diffraction data were collected from a perdeuterated crystal 
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(Fig. 1a) using ILL’s high flux thermal diffractometer D19. This instrument has fixed wavelength options of 0.95 Å, 
1.17 Å, 1.46 Å and 2.42 Å. The wavelength dependence of the imaginary part of the neutron anomalous disper-
sion is relatively smooth and is still significant over the hot and thermal neutron range of 0.3 to 3 Å wavelength. 
For this study a neutron wavelength of 1.17 Å was selected on the basis of a compromise between the proximity 
to the Cd absorption resonance at 0.68 Å19, and the difficulty of resolving Bragg reflections at short wavelength. 
Diffraction data were collected at room temperature up to 1.75 Å resolution and were corrected for neutron atten-
uation arising almost solely from the single 113Cd atom in the unit cell. The quality of the neutron data is shown 
by the low value of the precision indicating (multiplicity weighted) Rp.i.m. value of 14.9% for the highest resolution 
shell and 4.2% overall (see Table 1).
The data were analysed for the presence of an anomalous signal using SCALA20 and SHELXC21, which both 
showed a high anomalous signal-to-noise ratio across most of the resolution range (Fig. 1b). Harker sections 
calculated from the anomalous Patterson map show a strong 9.0-sigma peak corresponding to the 113Cd atom 
(Fig. 1c). Furthermore, the ratio of Ranom values overall and across most of the resolution range to Rp.i.m. values are 
greater than 1, indicating an anomalous signal (though care has to be taken in interpretation as Ranom does not 
take into account redundancy)22,23. The X-ray data can be used as a basis for comparison, as it also contains an 
anomalous signal. The equivalent Harker section calculated using the X-ray data with the same resolution range 
as the neutron data (data to 1.75 Å) has a corresponding peak of 7.9-sigma. The comparison against the X-ray data 
is interesting as both data sets were collected at wavelengths remote from the anomalous edges concerned (1.17 Å 
experiment wavelength against 0.68 Å for neutrons, and 0.98 Å against 3–3.5 Å for the X-ray LI-LII-LIII anom-
alous edges). To try to compare the experimental results against the theoretical anomalous signal, the expected 
anomalous signal as a contribution to |F| was estimated using Δ F/F ≈ √ 2. (√ Na.Δ b”)/(√ Np.bav), where Na is the 
number of anomalously scattering atoms, Np is the number of protein atoms, bav is the average neutron scatter-
ing length for a protein atom and b” is the imaginary contribution to the scattering length at the wavelength of 
interest (as adapted from Hendrickson and Teeter24). The estimation is 6.7% irrespective of the scattering angle 
(neutron scattering amplitudes do not fall off appreciably with increasing scattering angle, since the atomic nuclei 
Figure 1. (a) The 4.5 mm3 113Cd substituted crystal as obtained in the sitting drop container. Scale bar is 
100 μm. (b) Harker section at z = 0.5 from the neutron Patterson map computed by PATTERSON/CCP4i32. 
Contours levels are shown from 2 to 10 sigma. (c) Plot of the anomalous signal to noise ratio (< d”/sig> ) 
obtained from SHELXC (red line) and correlation coefficient as a function of resolution (blue line, from CCP4).
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are effectively point scatterers, if the effects of atomic displacement parameters are not considered). This com-
pares against the measured Ranom (which compares reflection pairs for their experimentally measured intensity 
differences) of 7.5% overall. Care needs to be taken as the estimation is based upon |F| whilst the measurement is 
based upon I. The equivalent figures for the X-ray data are 1.5% at 10 Å resolution and 2.8% at 1.75 Å resolution 
and an Ranom of 2.8%.
SHELXC/D/E21 were used to determine the coordinates of the 113Cd atom and to phase a neutron Fourier 
map. This experimental density map is of high quality and shows clear features corresponding to the protein 
structure (Fig. 2a). Using the phased diffraction data, SHELXE automatically built an initial model of 38 polyala-
nine residues out of a total of 54. Cycles of manual construction and refinement gave a final model consisting of 
all 54 residues and 49 D2O molecules with R/Rfree of 23.3/28.6% (see Table 1). The overall correlation coefficient 
between the original SHELXE experimentally phased map and the final refined model calculated phased map is 
60.3% including all data to 2.30 Å resolution.
Discussion
The use of neutron anomalous diffraction differences was first suggested in the 1960s for crystals containing 
atoms such as 113Cd, 149Sm, 151Eu and 157Gd10. At the time, an anomalous neutron data collection experiment 
required very large crystals and fewer than 100 reflections could be measured per day; hence experiments were 
very expensive in neutron beam time and far from tenable as a realistic phasing method for proteins. The pres-
ent demonstration takes advantage of the neutron anomalous scattering properties of 113Cd, the availability of 
modern high-intensity monochromatic neutron beamlines such as D19 at the ILL, and protein perdeuteration 
to determine the structure of a biological macromolecule using de novo phasing in a reasonable timescale. As 
pointed out by Bacon19, isotopic replacement of hydrogen by deuterium atoms in a crystal provides a crucial 
Beamline D19 (ILL) ID23-1 (ESRF)
Data collection
Type of radiation diffracted Neutron Synchrotron X-ray
Crystal volume (mm3) 4.5 0.12
Time/frame (s) 50 n/a
Data collection (days) 13 n/a
Temperature (°K) 295 295
Space group P21 21 21 P21 21 21
Wavelength (Å) 1.17 0.98
Cell dimensions a, b, c (Å) 34.44, 35.14, 43.78 34.44, 35.14, 43.78
Resolution range (Å) 34.44–1.75 43.78–1.02
Rmerge 0.142 (0.457) 0.033 (0.714)
Rp.i.m. 0.042 (0.149) 0.018 (0.341)
Mn I/σ (I) 12.9 (5.4) 25.4 (3.0)
Wilson B-factor (Å2) n/a 11.24
Mn(I) half-set correlation 
CC(1/2) 0.996 (0.941) 0.999 (0.704)
Completeness (%) 99.9 (99.9) 91.8 (82.7)
Multiplicity 13.4 (10.6) 6.2 (6.0)
Number observations 74266 (8426) 157832 (19705)
Number unique reflections 5560 (792) 25412 (3282)
Anomalous completeness (%) 100.0 (100.0) 89.8 (80.1)
Anomalous multiplicity 6.6 (5.1) 3.3 (3.1)
Ranom 0.075 0.028
Refinement
PDB code 5AI2 5AI3
Rwork/Rfree (%) 23.3/28.6 10.7/12.6
R.m.s. deviations
Bonds (Å) 0.003 0.024
Angles (°) 0.613 1.365
Table 1.  Neutron and X-ray data collection characteristics and statistics obtained from SCALA with 
refined model parameters obtained from PHENIX.REFINE. Overall values for the selected resolution ranges 
are presented. Values in parentheses are for the highest resolution shell. Data were collected from one crystal 
for each structure. Note the X-ray data completeness is 82.7% because of the integration of valid reflections in 
the corners of the square detector. Rmerge = (Σ(I − < I> )/Σ(I); where I is the intensity measured for a given 
reflection, < I> is the average intensity for multiple measurements of this reflection. Rp.i.m. = (Σ [1/(N − 1)]1/2 
Σ |I − < I> |)/Σ (I)22 Ranom = Σ |Δ I±|/Σ < I> Rwork = Σ ||Fobs| − |Fcalc||/Σ |Fobs|; where Fobs and Fcalc are 
the observed and calculated structure factor amplitudes, respectively, for 95% of the reflection data used in 
refinement. Rfree = Σ ||Fobs| − |Fcalc||/Σ |Fobs|; for 5% of the reflection data excluded during the refinement.
www.nature.com/scientificreports/
4Scientific RepoRts | 6:31487 | DOI: 10.1038/srep31487
advantage in all but eliminating hydrogen incoherent scattering and thus enhancing the visibility of the anoma-
lous signal. Advanced facilities that have developed for macromolecular deuteration now permit the production 
of suitably labelled protein crystals on a routine and reliable basis16. It should be noted that this method may 
provide a useful complement to X-ray anomalous phasing approaches – particularly where structure determi-
nation at room or physiological temperature is advantageous25. In the current study the anomalous scatterer was 
introduced in the metal chelating site using chemical reagents to remove the native iron prior to isomorphous 
replacement with the 113Cd isotope. In future studies one can envisage the soaking of anomalous scatterers into 
macromolecular crystals in a way that is routinely used in X-ray diffraction studies (see for example26 and ref-
erences therein). Anomalous protein phasing work using X-rays can be delicate when carried out at room tem-
perature, and neutron approaches, for which radiation damage effects are essentially negligible, provide a way of 
tackling these problems. Experiments close to physiological temperatures can highlight structural differences 
induced by cryo-cooling, and which may be more representative of in vivo structures and their resulting function-
alities. This is reflected in the recent upsurge of interest in room temperature structures stimulated by FEL studies, 
including the work of Lui et al. who determined a GPCR crystal structure at room temperature27. This structure 
showed distinct thermal motions and residue conformations different to the cryo-cooled structure.
The confluence of new spallation neutron sources, high-performance detectors and ready access to per-
deutered proteins is paving the way to practical perspectives for neutron phasing methods. The impact of this 
approach is likely to be greatly enhanced by the fact that time-of-flight measurement at spallation neutron sources 
will, in a single experiment, provide diffraction data over the whole wavelength range accessible to a given instru-
ment. Plots of the real (b’) and imaginary (b”) components of the neutron scattering length for selected isotopes 
are provided in Fig. 3, highlighting the availability of an anomalous signal across neutron wavelength ranges. This 
offers key advantages given that anomalous differences will de facto be available over a wide wavelength range 
encompassing the resonance energies of isotopes that are relevant for the study of biological crystals.
For convenience, standard criteria were used during phasing of the rubredoxin data. We furthermore opted 
not to carry out solvent flattening approaches so as to minimise assumptions about the structure/solvent in evalu-
ating the phasing power of the system. SHELX was therefore directed to perform zero cycles of solvent flattening 
and the two resulting neutron scattering density maps (corresponding to the original and inverted hands of the 
cadmium substructure) were distinguished on the basis of visual inspection, which showed the inverted hand to 
be the correct one for phasing. This shows that the data and de novo phasing were of high quality. In future work 
on the methodology, it would be desirable to adapt current crystallographic software to better accommodate 
neutron experiments. This would allow the approach to be fully integrated with standard data analysis packages 
and be more accessible to the wider scientific community. Furthermore, the increased availability of specialised 
support laboratories for the production of deuterated protein material and optimised crystal growth would bene-
fit the community at large and further enhance the exploitation of neutron spallation sources in this area.
Figure 2. The neutron scattering density maps near the hydrophophobic core of Pf rubredoxin (Trp36, 
Tyr10, Phe48) rendered with PYMOL43 are shown. (a) The experimental phased map from SHELXE (2.30 Å 
resolution, contoured at 0.8 sigma in orange). (b) The 2Fo-Fc map from the refined final model (1.75 Å 
resolution, contoured at 1.5 sigma in blue).
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Methods
113Cd-substituted perdeuterated Pyrococcus furiosus (Pf) rubredoxin (Ru) preparation. The 
pET28a plasmid encoding a synthetic gene for Pf Ru was obtained from GeneArt (Life Technologies, USA). The 
perdeuterated iron substituted oxidised form of the protein was produced as described elsewhere18,28 and vali-
dated by mass spectrometry. The apoprotein was obtained using a previously reported procedure29, adapted for 
Pf Ru. All buffer constituents except trichloroacetic acid and beta-mercaptoethanol (BME) were filtered through 
a Chelex resin to remove iron contamination. The Fe-containing protein was denatured on ice with 15% trichlo-
roacetic acid (TCA), 0.5 M beta-mercaptoethanol (BME), with gentle tube inversion for 5 min. The precipitate 
was recovered by centrifugation at 10000 rpm for 3 min in a table top centrifuge. The white protein precipitate 
was redissolved for 20 min in 0.5 M Tris base + 60 mM BME. This procedure was repeated twice. To introduce 
cadmium, an equivalent volume of 25 mM Tris pH7.5 was added to the concentrated protein liquor prior to the 
addition of 2 molar equivalents of 113CdCl2 (min. 95% isotope enriched, BuyIsotope, Sweden). The clear protein 
solution was exchanged using centrifugal concentration devices against D2O/Tris 25 mM pD7.5, KCl 150 mM 
until reaching 99.75% D2O theoretical content at ~80 mg/ml of final protein concentration. During this concen-
tration process, excess soluble 113Cd was eliminated.
Crystallogenesis. Crystal growth followed a multi-step process as described below:
1. The 113Cd rubredoxin solution (~80 mg/ml, see above) was equilibrated for 48 hours in a sitting drop con-
tainer against 1:1 volume of 3.8 M NaH2PO4 : 3.8 M K2HPO4 in > 99.7% D2O28.
2. Microseeds of Fe-substituted Pf D-rubredoxin, obtained according to a method described by Jenney & 
Adams28 and by Cuypers et al.18, were added to a pre-equilibrated 113Cd rubredoxin solution. Small hybrid 
crystals of 113Cd and Fe Pf D-rubredoxin were obtained. These contained the red coloured microseed at the 
centre and clear 113Cd-substituted protein component at the exterior.
3. The 113Cd part of one small hybrid crystal (above) was crushed and used to seed growth of purely 113Cd 
substituted crystals by repeating steps 1 and 2 to produce crystals with dimensions in the range of 
0.1–0.5 mm.
4. A sitting drop of protein (~120 μ l) was pre-equilibrated at room temperature against a well solution of 2 ml 
of 3.7 M equimolar NaH2PO4 : K2HPO4 in a purpose-designed sitting drop container. Numerous small 
protein crystals (from stage three) were added to the pre-equilibrated sitting drop, and 20–40 μ l of pure 
D2O was progressively added until the crystals were completely dissolved. The drop tray was then closed 
hermetically and allowed to equilibrate for 48 h against the 3.7 M salt solution.
5. A 50 μ m large defect-free bipyramidal crystal from the third stage was washed in fresh 3.7 M phosphate 
buffer in D2O and transferred with a nylon loop into the 120 μ l pre-equilibrated protein-phosphate buffer 
container (from stage four). A large crystal of volume 4.5 mm3 (Fig. 1a) used for the diffraction study was 
acquired within 6 days and encapsulated in a 3 mm diameter quartz capillary, sealed with epoxy resin, and 
mounted on a goniometer head for the neutron diffraction experiment.
Figure 3. Calculated values of b’ and b” for E = 178 meV neutron resonance of 113Cd, 151Eu, 149Sm and 157Gd 
derived from Breit-Wigner formula with the scattering length = + −
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(Er is the resonance energy, Γ is the total width of the resonance Γn is the width of resonance for re-emission 
of the neutron with its original energy, k = 2π/λ is the wavenumber and R the nuclear radius). Resonance 
parameters Er, Γ n, Γ were taken from44.
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X-ray data collection, processing and model refinement. Verification of the 113Cd-substituted pro-
tein structure was carried out by X-ray crystal diffraction and X-ray fluorescence prior to the large crystal growth. 
X-ray data collection was performed at 295 K on ESRF (Grenoble, France) beamline ID23-130 using a very heavily 
attenuated X-ray beam with a quartz capillary encapsulated crystal. The crystallographic data are summarised 
in Table 1. Data integration was carried out using XDS31. The resulting intensities were merged and scaled with 
SCALA32. Molecular replacement was performed using MOLREP/CCP433 using an X-ray structure of the oxi-
dised form of Fe-Pf D-rubredoxin at 295 K (pdb code 4AR5) as the probe. Refinement was performed using data 
to 1.02 Å resolution with automatic water placement using PHENIX.REFINE34 in conjunction with COOT35. All 
atoms, including water oxygens but with the exception of deuterium atoms, were refined with anisotropic atomic 
displacements. The final model is accessible under PDB code 5AI3.
Neutron data collection, processing and model refinement. Using instrument D19 at the ILL 
(Grenoble, France), a complete and highly redundant neutron dataset was recorded using omega step-scans of 
0.07° with an exposure time of 50 seconds per image at a neutron wavelength of 1.17 Å for the majority of the 
images. The merged data contains a 99.9% complete set of reflections with high redundancy to 1.75 Å resolu-
tion. The dataset was processed with the ILL program RETREAT36 and corrected for effective neutron atten-
uation using PLATON37 with a μ value of 1.54 cm−1 at 1.17 Å wavelength (μ = (∑ (coherent absorption cross 
section) + ∑ (incoherent absorption cross section)) * n atoms/cell volume). The neutron cross section of 113Cd 
used was 19800 (+ /− 400) barn for 1.17 Å wavelength38. The reflection data from RETREAT was converted into 
mtz format with POINTLESS39 using unit cell parameters refined from the X-ray data (a = 34.44 Å; b = 35.14 Å; 
c = 43.78 Å, α = β = γ = 90°; P212121). Anomalous pairs were handled separately whilst merging data using 
SCALA up to a resolution of 1.75 Å. The program MTZ2SCA40 was used to convert the neutron anomalous 
data mtz file into sca file format for the purpose of compatibility with HKL2MAP41 and SHELXC/D/E21. Data 
corresponding to a resolution of better than 2.3 Å resolution were excluded from SHELXD for single anomalous 
dispersion (SAD) calculations. For convenience, SHELXD was directed to search for a single atom of Cd using 
10,000 trials and found one position. Density modification was not performed in SHELXE and the resolution 
was extrapolated to 1.5 Å. The neutron scattering maps calculated using the non-solvent modified experimen-
tal phases of the original and inverted hands of the Cd substructure used for the SHELXE run showed clear 
differences with protein structure features readily identifiable in the map corresponding to the phasing using 
the inverted hand substructure. This phase set was therefore used thereafter. At the end of the SHELXE run, the 
correlation coefficient of the best partial structure trace against neutron data was 18.7% with a total of 38 alanine 
residues built. The output file containing the experimental phases from SHELXE was converted into an mtz file 
format using F2MTZ (script from T. Grüne). A free Rflag set of reflections of 5% was generated with IMPORT/
CCP4. This reflection file was used in ARP/wARP42. Neutron data collection took 13 days, with subsequent inte-
gration, neutron attenuation correction and phasing achieved using routine crystallography software in ~2 days. 
The ARP/wARP model was enhanced with cycles of manual building with COOT together with neutron data 
refinement with a modified scattering table version of PHENIX.REFINE for the 113Cd isotope (neutron coherent 
scattering length density of 113Cd is − 8.0 fm) with automatic water placement. Model refinement statistics are 
included in Table 1. The structure has been deposited under PDB accession code 5AI2.
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